Skip to main content

Table 1 Subject baseline characteristics

From: FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET

Subject # Age (yrs) Gender Ethnicity Positive for CS by HRS criteria? Cardiac presentation Biopsy proven extra-cardiac sarcoidosis? Initial assessment or reassessment? On active treatment at the time of current imaging? MRI findings compatible with CS?
1 44 Male Caucasian Yes Bifascicular block Yes Reassessment Yes, methotrexate/prednisone Yes
2 64 Male Caucasian No Cardiomyopathy Yes Initial No No
3 49 Male Caucasian Yes Complete AV block Yes Initial No Yes
4 49 Female African-American Yes Complete AV block Yes Initial No No
5 57 Male Caucasian Yes Complete AV block Yes Reassessment No Not performed
6 56 Male Caucasian Yes Cardiomyopathy Yes Reassessment No Not performed
7 54 Female Caucasian No None Yes Initial No No
8 66 Male Caucasian Yes Complete AV block Yes Reassessment Yes, methotrexate Yes
9 68 Male Caucasian Yes None Yes Initial No Yes
10 57 Male Caucasian Yes Ventricular tachycardia Yes Reassessment Yes, prednisone Yes
11 54 Female Caucasian Yes Complete AV block Yes Initial No No
12 57 Male Caucasian Yes Complete AV block Yes Initial No Yes
13 58 Female Asian Yes Complete AV block Yes Initial No Yes
14 55 Female Asian Yes Complete AV block Yes Initial No Not performed